Johannes Hulthe

Johannes Hulthe

Director/Board Member at GUARD THERAPEUTICS INTERNATIONAL AB

54 year
Commercial Services
Health Technology
Consumer Services

Profile

Dr. Johannes Hulthe, MD, is an Independent Director at Lipigon Pharmaceuticals AB, an Independent Director at Guard Therapeutics International AB, a Chairman at Antaros Renostic AB and a Chief Executive Officer & Director at Antaros Medical AB.
He is on the Board of Directors at Lipigon Pharmaceuticals AB, Guard Therapeutics International AB, Antaros Medical AB, Antaros Holding AB and Metynex Pharmaceuticals AB.
Dr. Hulthe was previously employed as a Vice President by AstraZeneca AB.
He received his graduate degree from the University of Gothenburg and a doctorate degree from the University of Gothenburg.

Johannes Hulthe active positions

CompaniesPositionStart
GUARD THERAPEUTICS INTERNATIONAL AB Director/Board Member 2019-05-28
LIPIGON PHARMACEUTICALS AB Director/Board Member 2019-12-31
Founder -
Antaros Renostic AB Chairman -
Antaros Holding AB Director/Board Member -
Metynex Pharmaceuticals AB Director/Board Member -
All active positions of Johannes Hulthe

Former positions of Johannes Hulthe

CompaniesPositionEnd
Corporate Officer/Principal 2013-12-31
See the detail of Johannes Hulthe's experience

Training of Johannes Hulthe

University of Gothenburg Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Johannes Hulthe's experience

Connections

23

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
GUARD THERAPEUTICS INTERNATIONAL AB

Health Technology

LIPIGON PHARMACEUTICALS AB

Health Technology

Private companies5

Commercial Services

Commercial Services

Antaros Renostic AB

Antaros Holding AB

Metynex Pharmaceuticals AB

See company connections
  1. Stock Market
  2. Insiders
  3. Johannes Hulthe